Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

NCT02876679 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Graft vs Host Disease

Interventions

DRUG: Cyclophosphamide
DRUG: Anti-Thymocyte Globulin
DRUG: Conditioning regimen

Sponsor

Assistance Publique - Hôpitaux de Paris